In the last trading session, 1.49 million Intellia Therapeutics Inc (NASDAQ:NTLA) shares changed hands as the company’s beta touched 1.86. With the company’s per share price at $23.72 changed hands at $0.12 or 0.51% during last session, the market valuation stood at $2.29B. NTLA’s last price was a discount, traded about -100.17% off its 52-week high of $47.48. The share price had its 52-week low at $19.37, which suggests the last value was 18.34% up since then. When we look at Intellia Therapeutics Inc’s average trading volume, we note the 3-month average coming to 1.48 million.

Intellia Therapeutics Inc (NASDAQ:NTLA) trade information

Instantly NTLA was in green as seen at the end of in last trading. With action 7.92%, the performance over the past five days has been green. The jump to weekly highs of 24.99 added 0.51% to the stock’s daily price. The company’s shares are showing year-to-date downside of -22.20%, with the 5-day performance at 7.92% in the green. However, in the 30-day time frame, Intellia Therapeutics Inc (NASDAQ:NTLA) is -4.28% down.

Intellia Therapeutics Inc (NTLA) estimates and forecasts

Data shows that the Intellia Therapeutics Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -10.42% over the past 6 months, a -2.77% in annual growth rate that is considerably lower than the industry average of 13.00%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -22.30%. The 2024 estimates are for Intellia Therapeutics Inc earnings to decrease by -1.29%, but the outlook for the next 5-year period is at 30.00% per year.